Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients.
Masashi KatoAkihiro HirakawaYumiko KobayashiAkiyuki YamamotoRyo IshidaOsamu KamihiraTomoyasu SanoTsuyoshi MajimaShohei IshidaYasuhito FunahashiNaoto SassaTakashi FujitaYoshihisa MatsukawaRyohei HattoriMomokazu GotohToyonori TsuzukiPublished in: The Prostate (2019)
Some cases with IDC-P responded to ADT and demonstrated favorable clinical outcomes similar to those of cases without IDC-P. These findings indicate that cases with IDC-P are heterogeneous.